MOXO Terms of Service
Neuro-Technology Solutions Ltd. (“Neurotech” or “us,” “our,” “we“) is the creator and owner of MOXO™ d-CPT Test (the “Assessment“), which can assist in diagnostic activities relating to Attention Deficit Hyperactivity Disorder and is provided through Neurotech’s website https://www.neurotech-solutions.com/ (“Site“). These Terms of Service (the “Terms“) govern your access to and use of the Site and services available through the Site, including the Assessment and the Reports (as defined below) (collectively, the “Services“). Our Privacy Notice, available at https://moxo.ai/privacy-policy/ (“Privacy Notice“) governs our collection, processing and transfer of any Personal Data (as such term is defined in the Privacy Notice). “You” means any institution, clinic, healthcare facility or other such entity (“Customer“) or an employee or colleague designated by a Customer to access the Services (“Permitted User“).
Please read these Terms carefully. These Terms govern your access to and use of the Site and Services. By clicking on the button marked “I agree,” you signify your consent to these Terms. Changes may be made to these Terms from time to time. Your continued use of the Site or Services will be deemed acceptance to the amended or updated Terms. If you do not agree to any of these Terms, please do not click the button marked “I agree” or use the Site and/or Services.
If you are registering on behalf of a Customer, you represent that you are authorized to enter into, and bind the Customer to these Terms and register for the Services. You are solely responsible for ensuring that these Terms are in compliance with all laws, rules, and regulations applicable to you and the Customer and the right to access the Services is revoked where these Terms or use of the Services is prohibited. The Customer and Neurotech may sign a separate agreement relating to the Customer’s use of the Services (“Agreement”). In case of a conflict between the provisions of the Terms and the provisions of the Agreement, the provisions of the Agreement shall govern and prevail.
Last updated: June 2023